Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,426 | -14,472 | -9,247 | -3,864 | -15,754 |
| Depreciation Amortization | 447 | 336 | 234 | 131 | 1,279 |
| Accounts payable and accrued liabilities | 741 | -416 | 767 | -468 | 1,002 |
| Other Working Capital | -1,555 | -2,754 | -1,869 | -3,519 | 993 |
| Other Operating Activity | 3,078 | 2,897 | 557 | 1,002 | 831 |
| Operating Cash Flow | $-19,715 | $-14,409 | $-9,558 | $-6,718 | $-11,649 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -918 | -18 | -18 | -7 | -31 |
| Purchase Of Investment | -11,245 | -11,245 | N/A | N/A | N/A |
| Other Investing Activity | -252 | 64 | 54 | 54 | 0 |
| Investing Cash Flow | $-12,415 | $-11,199 | $36 | $47 | $-31 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -516 | N/A | N/A | N/A | N/A |
| Debt Repayment | -1,121 | -923 | -627 | -334 | -1,181 |
| Common Stock Issued | 46,505 | 41,193 | 37,941 | 41,193 | 13,650 |
| Other Financing Activity | 3,000 | -3,252 | 0 | -2,965 | -355 |
| Financing Cash Flow | $47,868 | $37,018 | $37,314 | $37,894 | $12,114 |
| Beginning Cash Position | 8,034 | 8,034 | 8,034 | 8,034 | 7,600 |
| End Cash Position | 23,772 | 19,444 | 35,826 | 39,257 | 8,034 |
| Net Cash Flow | $15,738 | $11,410 | $27,792 | $31,223 | $434 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,715 | -14,409 | -9,558 | -6,718 | -11,649 |
| Capital Expenditure | -918 | -18 | -18 | -7 | -31 |
| Free Cash Flow | -20,633 | -14,427 | -9,576 | -6,725 | -11,680 |